All In Biotech

Free tool

FAERS Monitor: Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019952 or its brand name (Heparin Sodium 25,000 Units In Dextrose 5% In Plastic Container, Heparin Sodium). Reports on generic versions are filed under their own applications.

Reports

723

Serious

648

90% of reports

Hospitalization

350

Death reported

145

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective319
  • general physical health deterioration86
  • hyponatraemia85
  • stress85
  • multiple organ dysfunction syndrome84
  • sepsis84
  • abdominal pain79
  • ascites78
  • ventricular fibrillation78
  • abdominal distension77
  • appendicitis77
  • appendicolith77
  • nausea77
  • off label use77
  • condition aggravated76

Reports by year received

View as table
YearReports
20091
20126
20132
20153
201622
201723
201845
201932
202029
202162
202254
2023163
2024202
202547
202632

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,436 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
appendicolithSignal777232.95697.1440,234
appendicitisSignal77241.8195.618,081
ventricular fibrillationSignal78205.7166.715,583
multiple organ dysfunction syndromeSignal8486.570.77,004
ascitesSignal7877.462.75,798
hyponatraemiaSignal8544.036.03,531
stressSignal8534.328.12,724
sepsisSignal8421.917.91,664
general physical health deteriorationSignal8621.617.71,680
abdominal distensionSignal7721.517.41,489
abdominal painSignal799.98.0629
condition aggravatedSignal767.35.9411
drug ineffectiveSignal3197.06.51,758
nauseaSignal772.82.393
off label useSignal772.62.175

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.